Freakonomics Radio   /     615. Is Ozempic as Magical as It Sounds?

Summary

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.

Subtitle
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut micro
Duration
00:56:49
Publishing date
2024-12-12 01:00
Link
https://freakonomics.com
Contributors
  Freakonomics Radio + Stitcher
author  
Enclosures
https://dts.podtrac.com/redirect.mp3/tracking.swap.fm/track/0bDcdoop59bdTYSfajQW/pdst.fm/e/stitcher.simplecastaudio.com/2be48404-a43c-4fa8-a32c-760a3216272e/episodes/89cf74ba-c76f-4a3c-ab8b-e74870f62787/audio/128/default.mp3?aid=rss_feed&awCollectionId=
audio/mpeg

Shownotes

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.

 

  • SOURCES:
    • Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine.